
Endoscopic Minimally invasive &
Hybrid heart surgery
PUTTING YOUR HEART FIRST
Director of the International Heart Surgery Center Greece- HYGEIA
Director of the 1st Cardiac Surgery Clinic – HYGEIA
(Associate) Full Professor of Surgery School of Medicine-National University of Singapore
MD,PD(GER), FRCS, FAHA, FAMS, FAATS
Specialising in minimally invasive and endoscopic heart surgery, (Adj) Professor Theo Kofidis is known for his innovative techniques that enhance patient recovery and outcomes. With training from prestigious global institutions and guidance from esteemed mentors in heart surgery, his expertise is exceptional.
In Singapore, he has developed advanced heart surgery programs and led Centers of Excellence, earning numerous international accolades. As a respected surgical teacher, consultant, and author, Professor Kofidis is dedicated to advancing cardiac care and providing personalised treatment options.
Explore videos, articles, and educational resources showcasing (Adj) Professor Theo Kofidis’s innovative techniques and advancements in MICS.
Discover how MICS helps you have less surgery, quicker recovery times, and tailored solutions, all supported by evidence-based practices and cutting-edge techniques.
MINIMALLY INVASIVE BYPASS CARDIAC SURGERY
ROBOTIC CORONARY ARTERY BYPASS GRAFTING
MINIMALLY INVASIVE AORTIC VALVE REPAIR/REPLACEMENT VALVE SURGERY
MINIMALLY INVASIVE MITRAL REPAIR/REPLACEMENT VALVE SURGERY
TOTALLY ENDOSCOPIC AORTIC VALVE REPAIR / REPLACEMENT
TOTMINIMALLY INVASIVE AORTIC ANEURISM REPAIR
MINIMALLY ENDOSCOPIC MITRAL REPAIR/REPLACEMENT CARDIAC SURGERY
MINIMALLY INVASIVE SURGERY FOR COMBINED HEART CONDITIONS
MINIMALLY INVASIVE TRICUSPID VALVE SURGERY
MINIMALLY INVASIVE ARRHYTHMIA SURGERY
MINIMALLY INVASIVE ASD CLOSURE
MINIMALLY INVASIVE HEART TUMOR OPERATIONS
MINIMALLY INVASIVE MYOCARDIAL BRIDGE REPAIR
Coronary heart disease, or simply coronary heart disease, is caused when atherosclerotic plaques fill, ie fill, the lumen of the heart's blood vessels (called coronary arteries), and block blood flow to the heart.
Aortic valve stenosis is more commonly a disease of old age. It is caused by gradual hardening of the valve folds and calcium deposition, causing the valve to open with increasing difficulty.
Aortic valve insufficiency causes blood to reflux back into the left ventricle after each heart contraction. This causes the heart to expand, i.e. "inflate" the walls and cavities, while it gradually loses its elasticity.
Mitral regurgitation is the condition in which there is an abnormal return of blood (reflux) from the left ventricle to the left atrium through the mitral valve.
When the heart contracts it closes and when it expands it opens. Normally the opening of the valve is 4-6 square centimeters. If for some reason the mouth of the valve becomes smaller, this condition is called mitral valve stenosis
Aortic aneurysm is the dilation of the aorta 2.5 times its normal size. In essence, the wall of the aorta weakens and stretches, usually taking the form of a balloon. When the aneurysm exceeds 5.5 cm, the risk of wall rupture increases exponentially.
Tricuspid stenosis, on the other hand, involves a narrowing of the valve, preventing the flow of blood from the atrium to the ventricle.
Tricuspid valve insufficiency is a serious pathological condition.
Because the valve doesn't close tightly, blood backs up into the venous circulation, straining vital organs such as the liver, kidneys, and leg veins. Patients end up with swollen legs, kidney and liver failure, and eventually cirrhosis of the liver, the so-called cardiac cirrhosis.
Atrial fibrillation ablation is an invasive treatment that attempts to electrically isolate the "arrhythmogenic" areas of the heart (mainly in the pulmonary veins), which are responsible for causing atrial fibrillation.
Myocardial bridging is a condition in which a portion of one or more coronary arteries passes through the heart muscle instead of running on the surface. This can lead to compression of the artery during each heartbeat, causing reduced blood flow to the heart muscle.
Hypertrophic cardiomyopathy is a disease characterized by a large thickening of a part or even the whole heart and is due to an abnormality of the genetic material. The cells of the heart do not have the correct arrangement in some places and this causes the heart to malfunction.
Congenital heart diseases are the most common congenital anomalies, accounting for about 35% of all. They are structural abnormalities of the heart or adjacent large vessels, which fail to develop normally during pregnancy.
Heart tumors, the occurrence of which is rare, are essentially cells that multiply at a particularly rapid rate. A tumor can grow in either the heart or the pericardium. Tumors that start, develop and remain in the heart are called primary. Secondary tumors are defined as those that start in another part of the body and end up, i.e. metastasize, in the heart.
WHAT ARE THE ADVANTAGES OF
MINIMALLYINVASIVE HEART SURGERIES
– Much faster and better mobility
– Faster recovery to return to normal life
– Less Trauma, cut, blood loss, risk of infection, irregular heart-beat
– No cutting of bones
– Improved breathing (post operatively)
– Reduced length of hospitalisation
– Better cosmetics because of the small incisions on the skin.
– Increased patient satisfaction
Theo Kofidis Endoscopic Minimally Invasive & Robotic Cardiac Surgery provides the full spectrum of modern heart surgery, including the unique and complete platform of Minimally Invasive and Endoscopic heart surgery, aiming at lessening patient trauma and burden, and substantially improving the entire patient journey.
CONTACT
Director of the International Heart Surgery Center Greece- HYGEIA
Director of the 1st Cardiac Surgery Clinic – HYGEIA
(Associate) Full Professor of Surgery School of Medicine-National University of Singapore
MD,PD(GER), FRCS, FAHA, FAMS, FAATS
Είμαστε στην διάθεση σας όλο το 24ωρο για να σας εξυπηρετήσουμε για όλες τις παθήσεις καρδιάς και αορτής
Ώρες Λειτουργίας: 8:00-21:00